Skip to main content

Vanderbilt-Ingram Cancer Center

Vanderbilt-Ingram Cancer Center is a matrix center that integrates all of Vanderbilt’s cancer-related expertise and resources to alleviate cancer death and suffering through pioneering research; innovative patient-centered care; and evidence-based prevention, education, and community initiatives. Vanderbilt-Ingram was founded in 1993 and became an NCI-Designated Cancer Center in 1995 and a comprehensive cancer center in 2001. 

Vanderbilt-Ingram is an inclusive, collaborative, interdisciplinary cancer research community with more than 280 members dedicated to advancing discoveries in prevention, diagnosis, and treatment for both adult and pediatric cancers. The center is recognized for its strength in discovery, translation, and collaborative “team” science in areas of lung, breast, gastrointestinal, and genitourinary cancers, as well as robust world-leading cancer epidemiology with unique population laboratories for cancer discovery.

Vanderbilt-Ingram investigators have made discoveries in genomics, drug development, precision oncology, cancer epidemiology, health outcomes and control, early detection, prevention, and cancer disparities research that have shifted paradigms and changed practice and guidelines.

Read more about the Vanderbilt-Ingram Cancer Center.

Vanderbilt University

Comp
Ben Ho Park, MD, PhD
Director
691 Preston Research Building
Nashville, TN 37232-6838
(615) 936-1782
Admin Leader
Julia Schaum, MS
Senior Director for Research Administration
COE Leader
Debra Friedman, MD
Associate Director, Community Outreach and Engagement
CRTEC Leader
Ann Richmond, PhD
Associate Director for Research Education

Research Programs

Research Program Program Leaders
Breast Cancer Justin Balko, PharmD, PhD; Vandana Abramson, MD
Cancer Cell Biology Jin Chen, MD, PhD
Cancer Epidemiology Xiao-Ou Shu, MD, MPH, PhD; Martha Shrubsole, PhD
Cancer Health Outcomes and Control Daniel Barocas, MD, MPH; Stacie Dusetzina, PhD; Eric Grogan, MD, MPH
Gastrointestinal Cancer Cathy Eng, MD
Genome Maintenance David Cortez, PhD; William Tansey, PhD
Host-Tumor Interactions Jeffrey Rathmell, PhD; John Wilson, PhD
Translational Research and Interventional Oncology Douglas Johnson, MD, MSCI; Kristen Ciombor, MD, MSCI; Eben Rosenthal, MD

Shared Resources

Category Resource Directors
Cat 1: Laboratory Science Animal and Human Imaging Todd Peterson, PhD; Mark Does, PhD
Cat 1: Laboratory Science Bioanalytics and Proteomics Richard Caprioli, PhD; Kevin Schey, PhD
Cat 1: Laboratory Science Cell Imaging Matthew Tyska, PhD; Jay Jerome, PhD
Cat 1: Laboratory Science Chemical Synthesis and High-Throughput Analytics Gary Sulikowski, PhD; Joshua Bauer, PhD
Cat 1: Laboratory Science Flow Cytometry Eric Skaar, PhD; Scott Hiebert, PhD; David Flaherty,
Cat 1: Laboratory Science Genome Editing Mark Magnuson, MD; Jennifer Skelton, MS
Cat 1: Laboratory Science Genomic Sciences Simon Mallal, MBBS
Cat 1: Laboratory Science Immunophenotyping Jeffrey Rathmell, PhD; Kimberly Dahlman, PhD
Cat 1: Laboratory Science Survey and Biospecimen Qiuyin Cai, MD, PhD; Martha Shrubsole, PhD
Cat 1: Laboratory Science Translational Pathology James Goldenring, MD, PhD; M Washington, MD, PhD; Katherine Gibson-Corley, DVM, PhD
Cat 6: Biostatistics Data Science Yu Shyr, PhD; Travis Osterman, DO, MS
Last Updated
June 5, 2024